Intelligence · Patents
Patents expiring in 2026
Annual patent cliff calendar for 2026 — US pharmaceutical patents by expiration date.
- Patents
- 360
Quick answer
360 indexed pharmaceutical patents have expiration dates in 2026. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7138237
Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
granted -
US 7138384
Modulators of DNA cytosine-5 methyltransferase and methods for use thereof
granted -
US 7141434
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase
granted -
US 7141405
Chimeric GB virus B (GBV-B)
granted -
US 7141409
Hyaluronan synthase gene and uses thereof
granted -
US 7141661
Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
granted -
US 7141238
Compositions for reducing UV-induced inhibition of collagen biosynthesis in human skin
granted -
US 7141236
Methods and compositions for delivering macromolecules to or via the respiratory tract
granted -
US 7141233
Radionuclide labeling of vitamin B12 and coenzymes thereof
granted -
US 7141234
Imaging of drug accumulation as a guide to antitumor therapy
granted -
US 7141598
Imidazole derivatives, production method thereof and use thereof
granted -
US 7141671
Biphenyl derivatives
granted -
US 7141553
A3AR agonists for the treatment of inflammatory arthritis
granted -
US 7141589
Methods of inhibiting formation of vascular channels and methods of inhibiting proliferation
granted -
US 7141648
Synthesis of cyclosporin analogs
granted -
US 7141603
Antitumor agents
granted -
US 7144862
Orally administered peptides to ameliorate atherosclerosis
granted -
US 7144867
Anticancer glycoside compounds
granted -
US 7144916
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
granted -
US 7144986
Polypeptides comprising IL-6 ligand binding receptor domains
granted -
US 7144982
Polypeptides with therapeutic activity and methods of use
granted -
US 7144900
Pharmaceutical composition
granted -
US 7144918
Biologically active macrolides, compositions, and uses thereof
granted -
US 7144575
Methods for selectively stimulating proliferation of T cells
granted -
US 7144720
Protein and DNA thereof
granted -
US 7144875
Methods of treating fungal infections using lupeol
granted -
US 7144880
Compositions relating to novel compounds and targets thereof
granted -
US 7144723
Marine actinomycete taxon for drug and fermentation product discovery
granted -
US 7147806
Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
granted -
US 7148197
Orally administered small peptides synergize statin activity
granted -
US 7148376
Polymorphic forms of nateglinide
granted -
US 7148323
Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
granted -
US 7148201
Use of human plasma hyaluronidase in cancer treatment
granted -
US 7148196
Anticancer compounds and methods
granted -
US 7148251
Amino ceramide-like compounds and therapeutic methods of use
granted -
US 7148036
DNA molecules encoding cartilage-derived morphogenetic proteins
granted -
US 7148193
Compounds that bind to growth hormone receptor
granted -
US 7147863
UVA (> 360-400) and UVB (300-325) specific sunscreens
granted -
US 7150984
Attenuated human rotavirus vaccine
granted -
US 7151183
Processes for preparing amorphous atorvastatin hemi-calcium
granted -
US 7151115
Diphenylmethyl compounds useful as muscarinic receptor antagonists
granted -
US 7151100
Indole compounds useful for the treatment of cancer
granted -
US 7150875
Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine
granted -
US 7150871
Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6
granted -
US 7151087
CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection
granted -
US 7150766
Method of particle formation
granted -
US 7151101
Inhibitors of p38
granted -
US 7150869
Modified cytokines for use in cancer therapy
granted
Frequently asked questions
How many pharma patents expire in 2026?
360 published patents in our USPTO index have expiration dates falling in calendar year 2026.